Literature DB >> 20131876

A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Douglas G Mullen1, Ming Fang, Ankur Desai, James R Baker, Bradford G Orr, Mark M Banaszak Holl.   

Abstract

Functional nanoparticles often contain ligands including targeting molecules, fluorophores, and/or active moieties such as drugs. Characterizing the number of these ligands bound to each particle and the distribution of nanoparticle-ligand species is important for understanding the nanomaterial's function. In this study, the amide coupling methods commonly used to conjugate ligands to poly(amidoamine) (PAMAM) dendrimers were examined. A skewed Poisson distribution was observed and quantified using HPLC for two sets of dendrimer-ligand samples prepared using the amine-terminated form of the PAMAM dendrimer and a partially acetylated form of the PAMAM dendrimer that has been used for targeted in vivo drug delivery. The prepared samples had an average number of ligands per dendrimer ranging from 0.4 to 13. Distributions identified by HPLC are in excellent agreement with the mean ligand/dendrimer ratio, measured by (1)H NMR, gel permeation chromatography (GPC), and potentiometric titration. These results provide insight into the heterogeneity of distributions that are obtained for many classes of nanomaterials to which ligands are conjugated and belie the use of simple cartoon models that present the "average" number of ligands bound as a physically meaningful representation for the material.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131876      PMCID: PMC2836386          DOI: 10.1021/nn900999c

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  51 in total

1.  Counting the number of proteins coupled to single nanoparticles.

Authors:  Didier Casanova; Domitille Giaume; Mélanie Moreau; Jean-Louis Martin; Thierry Gacoin; Jean-Pierre Boilot; Antigoni Alexandrou
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

2.  Isolation of discrete nanoparticle-DNA conjugates for plasmonic applications.

Authors:  Shelley A Claridge; Huiyang W Liang; S Roger Basu; Jean M J Fréchet; A Paul Alivisatos
Journal:  Nano Lett       Date:  2008-03-11       Impact factor: 11.189

3.  Structure and function of nanoparticle-protein conjugates.

Authors:  M-E Aubin-Tam; K Hamad-Schifferli
Journal:  Biomed Mater       Date:  2008-08-08       Impact factor: 3.715

Review 4.  Nanotechnology applications in cancer.

Authors:  Shuming Nie; Yun Xing; Gloria J Kim; Jonathan W Simons
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

Review 5.  Therapeutic and diagnostic applications of dendrimers for cancer treatment.

Authors:  Jesse B Wolinsky; Mark W Grinstaff
Journal:  Adv Drug Deliv Rev       Date:  2008-03-04       Impact factor: 15.470

6.  Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.

Authors:  Andrzej Myc; Thomas B Douce; Niharika Ahuja; Alina Kotlyar; Jolanta Kukowska-Latallo; Thommey P Thomas; James R Baker
Journal:  Anticancer Drugs       Date:  2008-02       Impact factor: 2.248

7.  Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures.

Authors:  Elliott Hill; Rameshwer Shukla; Steve S Park; James R Baker
Journal:  Bioconjug Chem       Date:  2007-10-31       Impact factor: 4.774

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

9.  The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles.

Authors:  Douglas G Mullen; Ankur M Desai; Jack N Waddell; Xue-Min Cheng; Christopher V Kelly; Daniel Q McNerny; István J Majoros; James R Baker; Leonard M Sander; Bradford G Orr; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2008-08-26       Impact factor: 4.774

10.  Targeted quantum dot conjugates for siRNA delivery.

Authors:  Austin M Derfus; Alice A Chen; Dal-Hee Min; Erkki Ruoslahti; Sangeeta N Bhatia
Journal:  Bioconjug Chem       Date:  2007-07-14       Impact factor: 4.774

View more
  40 in total

1.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

2.  Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Authors:  Douglas G Mullen; Daniel Q McNerny; Ankur Desai; Xue-Min Cheng; Stassi C Dimaggio; Alina Kotlyar; Yueyang Zhong; Suyang Qin; Christopher V Kelly; Thommey P Thomas; Istvan Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2011-03-22       Impact factor: 4.774

3.  High-Performance Chromatographic Characterization of Surface Chemical Heterogeneities of Fluorescent Organic-Inorganic Hybrid Core-Shell Silica Nanoparticles.

Authors:  Thomas C Gardinier; Ferdinand F E Kohle; James S Peerless; Kai Ma; Melik Z Turker; Joshua A Hinckley; Yaroslava G Yingling; Ulrich Wiesner
Journal:  ACS Nano       Date:  2019-01-10       Impact factor: 15.881

4.  Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.

Authors:  Douglas G Mullen; Mark M Banaszak Holl
Journal:  Acc Chem Res       Date:  2011-08-03       Impact factor: 22.384

5.  Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting.

Authors:  Rahul Rattan; Somnath Bhattacharjee; Hong Zong; Corban Swain; Muneeb A Siddiqui; Scott H Visovatti; Yogendra Kanthi; Sajani Desai; David J Pinsky; Sascha N Goonewardena
Journal:  Bioorg Med Chem       Date:  2017-06-30       Impact factor: 3.641

6.  Self-assembly of four generations of RNA dendrimers for drug shielding with controllable layer-by-layer release.

Authors:  Xin Li; Mario Vieweger; Peixuan Guo
Journal:  Nanoscale       Date:  2020-07-30       Impact factor: 7.790

Review 7.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

8.  Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.

Authors:  Thommey P Thomas; Baohua Huang; Seok Ki Choi; Justin E Silpe; Alina Kotlyar; Ankur M Desai; Hong Zong; Jeremy Gam; Melvin Joice; James R Baker
Journal:  Mol Pharm       Date:  2012-08-07       Impact factor: 4.939

9.  Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.

Authors:  Su-Tang Lo; Stephan Stern; Jeffrey D Clogston; Jiwen Zheng; Pavan P Adiseshaiah; Marina Dobrovolskaia; Jongdoo Lim; Anil K Patri; Xiankai Sun; Eric E Simanek
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

10.  Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography.

Authors:  Ankur M Desai; Mark Andreae; Douglas G Mullen; Mark M Banaszak Holl; James R Baker
Journal:  Anal Methods       Date:  2011-01       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.